Rubenstein Elyse S MD is categorized under Internal Medicine Doctors in Philadelphia, PA and active since 2010.
Rubenstein Elyse S MD was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Elyse Rubenstein at the company’s single location by writing to 111 North 49th St, Philadelphia, Pennsylvania PA 19139 or by phoning (215) 471-2819. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Rubenstein Elyse S MD |
| Contact Person: | Elyse Rubenstein |
| Address: | 111 North 49th St, Philadelphia, Pennsylvania 19139 |
| Phone Number: | (215) 471-2819 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Rubenstein Elyse S MD was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Elyse Rubenstein for inquiries that concern Rubenstein Elyse S MD by calling the company number (215) 471-2819, as your correspondence is most welcome. Additionally, the physical location of the single location of Rubenstein Elyse S MD can be found at the coordinates 39.962761,-75.219655 as well as the street address 111 North 49th St in Philadelphia, Pennsylvania 19139.
For its online presence, you may visit Rubenstein Elyse S MD’s website at and engage with its social media outlets through on Twitter and on Facebook.